Our history

The reason why

Our purpose was creating a different workplace distant from the competitive academic atmosphere. A place where every member of the team is engaged within the project and feel free to share ideas, as well as where is able to combine personal and professional life. Building a sustainable environment, while receiving professional recognition and offering opportunities to grow further, respecting genders and believes of any kind. Zebrafish has made our inspiration and dreams come true: bringing ZeClinics’s culture into life.

2009

The world suffered a financial crisis which affected all sectors, including science. Back then, Davide d’Amico and Ignasi Sahún met at the Center for Genomic Regulation of Barcelona (CRG). While they were working together, Davide was studying his PhD and Ignasi was doing his second postdoc. In the end, Davide decided to join Ignasi’s doctoral project when they had the real chance of sharing many hours of life discussion which made them become good friends. Ignasi had previous experience as an entrepreneur whereas Davide, still working on his PhD, had managed to put together a business of his own. It was a little food service called Arancino which became very popular among tourists around Barceloneta neighborhood.

2011

Meanwhile, Javier Terriente had moved to Barcelona after finishing a postDoc stay in London in 2011. He joined Cristina Pujades’s laboratory, at the PRBB, where he met Simone Calzolari who was a Pre-Doc at that moment. Both had experience studying zebrafish development.  Simone and Davide became friends in Italy years ago, and they found each other in Barcelona, again. Finally, the four of them,  crossed paths with each other by different reasons and circumstances, started to meet up socially linked by a strong point in common; science. As a result of hours of conversations, experiments, sharing initiatives, future motivations, they became friends mostly aimed by sharing common feelings; unconformity and their eagerness to get to do things better.

2012 - 2013

The band used to meet at Davide´s Arancino basement in order to work on the creation of a potential business launch. The foundation of ZeClinics in 2013 was the result of all the hours worked in that basement.  Thanks to  Universitat Pompeu Fabra Business Shuttle, who supported ZeClinics from the beginning of the foundation, ZeClinics founders received training in business management. The Barcelona Biomedical Research Park became their working environment where they welcomed their first international clients who trusted their model, as well as the first contracted members of the team.

2015 - 2017

ZeClinics, as pioneers, completed its first biomedical crowdfunding through Capital Cell Platform to develop a cancer research project called ZeOncoTest. That campaign was a full success, and it represented, in 2017, the first partial exit of a biotech company after a crowdfunding campaign. The year after closing its round, another five Spanish biotech companies obtained financing for their projects.

2017 - 2019

ZeClinics got a SME instrument grant which worthed 1.8 million euros from Horizon 2020. The award was invested to develop a cardiovascular video-analysis software which collects and analyses different cardiovascular parameters on zebrafish and can be applied both;  in drug development and to study cardiotoxicity. ZeClinics experienced substantial growth. They opened an office in the Almogàvers Business Factory in Poblenou while looking for a larger laboratory. Back then, a public tender was opened in Germans Tries i Pujol Research Institute located in Can Ruti’s campus to develop a zebrafish plant within the Comparative Medicine and Bioimage Center of Catalonia. This project was in line with ZeClinics program of alternative models that fits with the 3Rs principles (Reduction, Refinement and Replacement). ZeClinics applied for it and finally won it, moving to their larger facilities in Badalona.

2019-2020

They founded ZeCardio Therapeutics, a small pharmaceutical company although ambitious, seeking to discover drugs related to cardiovascular diseases. In 2020, ZeCardio Therapeutics managed to raise 800.000 euros during the COVID-19 pandemic. At this moment and time ZeClinics’s team is composed by 30 members whom mostly are PhD, national and international scientists. ZeClinics has its own zebrafish facilities in one of the most modern bioimage centers of Europe, and regular clients located worldwide.

The reason why

Our purpose was creating a different workplace distant from the competitive academic atmosphere. A place where every member of the team is engaged within the project and feel free to share ideas, as well as where is able to combine personal and professional life. Building a sustainable environment, while receiving professional recognition and offering opportunities to grow further, respecting genders and believes of any kind. Zebrafish has made our inspiration and dreams come true: bringing ZeClinics’s culture into life.

2009

The world suffered a financial crisis which affected all sectors, including science. Back then, Davide d’Amico and Ignasi Sahún met at the Center for Genomic Regulation of Barcelona (CRG). While they were working together, Davide was studying his PhD and Ignasi was doing his second postdoc. In the end, Davide decided to join Ignasi’s doctoral project when they had the real chance of sharing many hours of life discussion which made them become good friends. Ignasi had previous experience as an entrepreneur whereas Davide, still working on his PhD, had managed to put together a business of his own. It was a little food service called Arancino which became very popular among tourists around Barceloneta neighborhood.

2011

Meanwhile, Javier Terriente had moved to Barcelona after finishing a postDoc stay in London in 2011. He joined Cristina Pujades’s laboratory, at the PRBB, where he met Simone Calzolari who was a Pre-Doc at that moment. Both had experience studying zebrafish development.  Simone and Davide became friends in Italy years ago, and they found each other in Barcelona, again. Finally, the four of them,  crossed paths with each other by different reasons and circumstances, started to meet up socially linked by a strong point in common; science. As a result of hours of conversations, experiments, sharing initiatives, future motivations, they became friends mostly aimed by sharing common feelings; unconformity and their eagerness to get to do things better.

2012 - 2013

The band used to meet at Davide´s Arancino basement in order to work on the creation of a potential business launch. The foundation of ZeClinics in 2013 was the result of all the hours worked in that basement.  Thanks to  Universitat Pompeu Fabra Business Shuttle, who supported ZeClinics from the beginning of the foundation, ZeClinics founders received training in business management. The Barcelona Biomedical Research Park became their working environment where they welcomed their first international clients who trusted their model, as well as the first contracted members of the team.

2015 - 2017

ZeClinics, as pioneers, completed its first biomedical crowdfunding through Capital Cell Platform to develop a cancer research project called ZeOncoTest. That campaign was a full success, and it represented, in 2017, the first partial exit of a biotech company after a crowdfunding campaign. The year after closing its round, another five Spanish biotech companies obtained financing for their projects.

2017 - 2019

ZeClinics got a SME instrument grant which worthed 1.8 million euros from Horizon 2020. The award was invested to develop a cardiovascular video-analysis software which collects and analyses different cardiovascular parameters on zebrafish and can be applied both;  in drug development and to study cardiotoxicity. ZeClinics experienced substantial growth. They opened an office in the Almogàvers Business Factory in Poblenou while looking for a larger laboratory. Back then, a public tender was opened in Germans Tries i Pujol Research Institute located in Can Ruti’s campus to develop a zebrafish plant within the Comparative Medicine and Bioimage Center of Catalonia. This project was in line with ZeClinics program of alternative models that fits with the 3Rs principles (Reduction, Refinement and Replacement). ZeClinics applied for it and finally won it, moving to their larger facilities in Badalona.

2019-2020

They founded ZeCardio Therapeutics, a small pharmaceutical company although ambitious, seeking to discover drugs related to cardiovascular diseases. In 2020, ZeCardio Therapeutics managed to raise 800.000 euros during the COVID-19 pandemic. At this moment and time ZeClinics’s team is composed by 30 members whom mostly are PhD, national and international scientists. ZeClinics has its own zebrafish facilities in one of the most modern bioimage centers of Europe, and regular clients located worldwide.

Our people

The success of a company comes with team work. Therefore, we made a special effort in creating a friendly working culture, focused on flexibility working hours, sharing profit with the staff and creating a continuous growing environment.

Everything we have achieved is thanks to have built a healthy company's culture which encourages intellectual freedom and achieve a successful team work.

We are all working together to generate better, safer, and more efficient research.

We can support your R&D project and make your research easy and fast
our-people-team https://www.zeclinics.com/wp-content/uploads/2020/11/zeclinics-our-people-team.jpg

We feel grateful to count with motivated scientists covering all different areas of drug discovery which goes from library screening, up to model generation and validation, safety and efficacy assessment,  and Zebrafish biology

Most of all our scientists hold a PhD title. They are flexible and have the ability to acquire in both basic and applied research projects, with a full perspective on the business translation of science.

Zeclinics Organizational Chart
Board
of Directors

Javier Terriente Davide D'Amico Simone Calzolari Ignasi Sahún

Javier
davide-damico davide-damico
simone-calzolari simone-calzolari
ignasi-sahun ignasi-sahun
CFO Advisory
(external)

Miguel Ezcurra

miguel-ezcurra-duotono miguel-ezcurra
Scientifc Advisory Board

Florian Engert

Scott C. Baraban